Sequential DICE combined withl-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma-Reference-Cited by-同舟云学术

Sequential DICE combined withl-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma

Published:2016-01-04 Issue:7 Volume:57 Page:1600-1606
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dong Li-Hua,Zhang Li-Juan,Wang Wen-Jia,Lei Wen,Sun Xing,Du Jian-Wei,Gao Xue,Li Gang-Ping,Li Yu-Fu

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1108415

Reference29 articles.

1. Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation Treatment

2. Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy

3. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

4. Classification of natural killer (NK) cell and NK-like T-cell malignancies [editorial; comment]

5. Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma;Hematology;2024-09-13

2. Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea;Cancer Research and Treatment;2023-11-10

3. Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells;Frontiers in Pharmacology;2023-03-01

4. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07

5. Long-Term Outcomes of Definitive Chemoradiotherapy for Early-Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Analysis From a Single Center;Cureus;2023-01-29